BIOMAT Database Logo BIOMAT Database Logo

[Isosorbide dinitrate spray: a comparative pharmacodynamic study with a sublingual preparation in patients with chronic cardiac insufficiency]. 1988

N Marchionni, and M Di Bari, and L Ferrucci, and G Moschi, and M Paoletti, and B Salani, and L Boncinelli, and S Fumagalli, and A Schneeweiss

UI MeSH Term Description Entries
D007548 Isosorbide Dinitrate A vasodilator used in the treatment of ANGINA PECTORIS. Its actions are similar to NITROGLYCERIN but with a slower onset of action. Cardonit 40,Dilatrate,Iso-Bid,Isodinit,Isoket,Isoket Retard-120,Isomak R,Isordil,Isotrate,Nitrosorbide,Sorbitrate,Sorbonit,Dinitrate, Isosorbide,Iso Bid,IsoBid,Isoket Retard 120,Isoket Retard120
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D005260 Female Females
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

N Marchionni, and M Di Bari, and L Ferrucci, and G Moschi, and M Paoletti, and B Salani, and L Boncinelli, and S Fumagalli, and A Schneeweiss
Effects of isosorbide dinitrate spray on central hemodynamics. Comparison with sublingual glyceryl trinitrate and isosorbide dinitrate.
January 1984, Arzneimittel-Forschung,
N Marchionni, and M Di Bari, and L Ferrucci, and G Moschi, and M Paoletti, and B Salani, and L Boncinelli, and S Fumagalli, and A Schneeweiss
Laryngeal oedema after isosorbide dinitrate spray and sublingual nifedipine.
July 1995, BMJ (Clinical research ed.),
N Marchionni, and M Di Bari, and L Ferrucci, and G Moschi, and M Paoletti, and B Salani, and L Boncinelli, and S Fumagalli, and A Schneeweiss
Comparative evaluation of a new formulation of isosorbide dinitrate oral spray and sublingual nitroglycerin tablets.
June 1990, The American journal of cardiology,
N Marchionni, and M Di Bari, and L Ferrucci, and G Moschi, and M Paoletti, and B Salani, and L Boncinelli, and S Fumagalli, and A Schneeweiss
[Hemodynamic and isotope study of the effects of sublingual and oral administration of isosorbide dinitrate in cardiac insufficiency].
January 1976, Coeur et medecine interne,
N Marchionni, and M Di Bari, and L Ferrucci, and G Moschi, and M Paoletti, and B Salani, and L Boncinelli, and S Fumagalli, and A Schneeweiss
Hemodynamic effects of oral and sublingual forms of isosorbide dinitrate in patients with acute coronary insufficiency.
February 1977, Texas medicine,
N Marchionni, and M Di Bari, and L Ferrucci, and G Moschi, and M Paoletti, and B Salani, and L Boncinelli, and S Fumagalli, and A Schneeweiss
Sublingual isosorbide dinitrate, topical isosorbide dinitrate and topical nitroglycerine in salvaging ischaemic myocardium.
December 1984, The Journal of the Association of Physicians of India,
N Marchionni, and M Di Bari, and L Ferrucci, and G Moschi, and M Paoletti, and B Salani, and L Boncinelli, and S Fumagalli, and A Schneeweiss
[Comparative invasive examination of the effect of isosorbide-5-mononitrate and isosorbide dinitrate in chronic coronary insufficiency].
April 1981, Die Medizinische Welt,
N Marchionni, and M Di Bari, and L Ferrucci, and G Moschi, and M Paoletti, and B Salani, and L Boncinelli, and S Fumagalli, and A Schneeweiss
[Clinical studies of isosorbide dinitrate spray in postoperative patients].
April 1991, Masui. The Japanese journal of anesthesiology,
N Marchionni, and M Di Bari, and L Ferrucci, and G Moschi, and M Paoletti, and B Salani, and L Boncinelli, and S Fumagalli, and A Schneeweiss
Bioavailability and pharmacokinetics of a new isosorbide dinitrate spray preparation in healthy volunteers.
August 1993, Arzneimittel-Forschung,
N Marchionni, and M Di Bari, and L Ferrucci, and G Moschi, and M Paoletti, and B Salani, and L Boncinelli, and S Fumagalli, and A Schneeweiss
Perioperative sublingual isosorbide dinitrate for the prevention of cardiac complications in cardiac patients undergoing noncardiac surgery.
January 2005, Angiology,
Copied contents to your clipboard!